MM-121

Search structure


Status:	Phase 2
Entry Type:	Antibody
Molecule Category:	UNKNOWN
UNII:	1N3L70MDFX

Indications

Mesh Heading	Maximum Phase	Reference
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms	Phase 1/Phase 2	ClinicalTrials
Breast Neoplasms	Phase 2	ClinicalTrials
Squamous Cell Carcinoma of Head and Neck	Phase 1	ClinicalTrials
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms	Phase 2	ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms	Phase 1	ClinicalTrials
Neoplasms	Phase 1	ClinicalTrials
Breast Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms	Phase 1	ClinicalTrials
Neoplasms	Phase 1	ClinicalTrials
Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms	Phase 2	ClinicalTrials
Breast Neoplasms; Triple Negative Breast Neoplasms	Phase 2	ClinicalTrials

Cross References

Resources	Reference
ChEMBL	CHEMBL2109402
FDA SRS	1N3L70MDFX

CONTENTS